search
Back to results

Hair Up Prospective Study

Primary Purpose

Hair Loss

Status
Withdrawn
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Hair Up
Placebo
Sponsored by
Shmuel Gonen Technologies Ltd.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Hair Loss

Eligibility Criteria

25 Years - 60 Years (Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • Women who report hair loss during the past 3 months prior to the study

Exclusion Criteria:

  • Disorders and medications affecting hair loss/growth, pregnancy, scarring alopecia

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Placebo Comparator

    Arm Label

    Hair Up

    Placebo

    Arm Description

    Outcomes

    Primary Outcome Measures

    Assessment of hair loss
    Pull test

    Secondary Outcome Measures

    Assessment of hair regrowth
    Photographic evaluation of the change in hair density according to the Savin score (scale of 1-mild to 9-severe)
    Quality of life questionnaire
    Assessment of quality of life byThe Women's Androgenetic Alopecia Quality of Life Questionnaire (WAAQOL)

    Full Information

    First Posted
    June 27, 2018
    Last Updated
    April 2, 2019
    Sponsor
    Shmuel Gonen Technologies Ltd.
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT03652701
    Brief Title
    Hair Up Prospective Study
    Official Title
    Hair Up Prospective Study
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    April 2019
    Overall Recruitment Status
    Withdrawn
    Why Stopped
    sponsor discretion
    Study Start Date
    April 1, 2019 (Anticipated)
    Primary Completion Date
    March 1, 2020 (Anticipated)
    Study Completion Date
    March 1, 2021 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Shmuel Gonen Technologies Ltd.

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No

    5. Study Description

    Brief Summary
    The objective of this study is to assess the performance of Hair Up on female pattern hair shedding and regrowth. 58 adult female patients suffering from hair loss will be evaluated in a single center prospective study

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Hair Loss

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    ParticipantCare ProviderInvestigatorOutcomes Assessor
    Allocation
    Randomized
    Enrollment
    0 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    Hair Up
    Arm Type
    Experimental
    Arm Title
    Placebo
    Arm Type
    Placebo Comparator
    Intervention Type
    Other
    Intervention Name(s)
    Hair Up
    Intervention Description
    Herbal topical
    Intervention Type
    Other
    Intervention Name(s)
    Placebo
    Intervention Description
    Placebo
    Primary Outcome Measure Information:
    Title
    Assessment of hair loss
    Description
    Pull test
    Time Frame
    1 month
    Secondary Outcome Measure Information:
    Title
    Assessment of hair regrowth
    Description
    Photographic evaluation of the change in hair density according to the Savin score (scale of 1-mild to 9-severe)
    Time Frame
    3 months
    Title
    Quality of life questionnaire
    Description
    Assessment of quality of life byThe Women's Androgenetic Alopecia Quality of Life Questionnaire (WAAQOL)
    Time Frame
    3 months

    10. Eligibility

    Sex
    Female
    Minimum Age & Unit of Time
    25 Years
    Maximum Age & Unit of Time
    60 Years
    Accepts Healthy Volunteers
    Accepts Healthy Volunteers
    Eligibility Criteria
    Inclusion Criteria: Women who report hair loss during the past 3 months prior to the study Exclusion Criteria: Disorders and medications affecting hair loss/growth, pregnancy, scarring alopecia

    12. IPD Sharing Statement

    Plan to Share IPD
    Undecided

    Learn more about this trial

    Hair Up Prospective Study

    We'll reach out to this number within 24 hrs